Involvement of the olfactory cleft is implicated in olfactory dysfunction observed in patients with COVID-19 infection, highlighting the anatomical and pathophysiological basis of anosmia and hyposmia in the context of SARS-CoV-2 infection.
December 2022
Myopericarditis following COVID-19 vaccination is a rare adverse event, according to an international study, providing reassurance regarding the safety profile of COVID-19 vaccines and the importance of ongoing surveillance.
November 2022
A high prevalence of neurological complaints persists one year after COVID-19 diagnosis, emphasizing the long-term impact of the disease on neurological function and the need for comprehensive post-acute care services for affected individuals.
November 2022
Lifestyle changes during the COVID-19 pandemic have contributed to the exacerbation of fatty liver disease associated with metabolic dysfunction, highlighting the complex interplay between environmental factors and metabolic health in disease progression.
November 2022
Researchers find that equitable distribution of COVID-19 vaccine can mitigate transmission risks in different geographic areas, emphasizing the importance of global vaccine equity in controlling the spread of the virus and preventing future outbreaks.
November 2022
The first longitudinal imaging study before and after SARS-CoV-2 infection, with controls, investigates structural brain changes associated with COVID-19, shedding light on the neurological consequences of the virus and potential long-term effects on brain health.
November 2022
The WHO warns of a possible increase in COVID-19 cases in Ukraine, citing the low number of tests conducted since the onset of the Russian offensive, which raises concerns about significant undetected coronavirus transmission and underscores the importance of robust surveillance systems.
November 2022
Masks will continue to be an important part of non-pharmaceutical interventions post-COVID-19 vaccination, serving as a preventive measure against viral transmission, particularly in high-risk settings and during outbreaks of emerging variants.
November 2022